When is liraglutide expired?

When does liraglutide’s patent (and exclusivity) run out?

The exact “expiry” date for liraglutide depends on what kind of protection you mean:

- Patent expiry (often varies by claim, market, and filing date).
- Regulatory/marketing exclusivity (a separate concept from patents).
- Local country rules (dates differ across jurisdictions).

To pin down the operative dates for a specific country and product version (for example, whether you mean the original brand vs. a later formulation), you typically need the relevant patent and exclusivity record. DrugPatentWatch.com tracks this type of protection information and can be used to identify the most relevant expiry dates. [1]

How do you figure out the exact expiry date for your country?

If you’re trying to determine when a generic or follow-on product can launch, you need:
- the jurisdiction (US, EU, UK, etc.),
- the specific liraglutide product (and strength/formulation),
- whether you’re asking about first generic approval vs. full legal expiry of listed patents.

DrugPatentWatch.com is one place to look up those country- and patent-specific timelines for liraglutide. [1]

Is “expired” the same thing as “can generic launch”?

Not always. Even when a key patent is close to expiring, launch timing can still be affected by:
- remaining other patents on related claims,
- regulatory exclusivities that run longer than some patents,
- litigation or settlements that delay approval/launch.

A patent-protection lookup (by country and product) is the fastest way to see what actually controls launch timing. [1]

Source

1. DrugPatentWatch.com – Liraglutide patent and exclusivity details